Abstract

Engineering human tissue with diverse cell types and architectures remains challenging. The cerebral cortex, which has a layered cellular architecture composed of layer-specific neurons organised into vertical columns, delivers higher cognition through intricately wired neural circuits. However, current tissue engineering approaches cannot produce such structures. Here, we use a droplet printing technique to fabricate tissues comprising simplified cerebral cortical columns. Human induced pluripotent stem cells are differentiated into upper- and deep-layer neural progenitors, which are then printed to form cerebral cortical tissues with a two-layer organization. The tissues show layer-specific biomarker expression and develop a structurally integrated network of processes. Implantation of the printed cortical tissues into ex vivo mouse brain explants results in substantial structural implant-host integration across the tissue boundaries as demonstrated by the projection of processes and the migration of neurons, and leads to the appearance of correlated Ca2+ oscillations across the interface. The presented approach might be used for the evaluation of drugs and nutrients that promote tissue integration. Importantly, our methodology offers a technical reservoir for future personalized implantation treatments that use 3D tissues derived from a patient’s own induced pluripotent stem cells.

Brain injuries can result in significant damage to the cerebral cortex, and restoring the cellular architecture of the tissue remains challenging. Here, the authors use a droplet printing technique to fabricate a simplified human cerebral cortical column and demonstrate its functionality and potential for future personalized therapy approaches.

Details

Title
Integration of 3D-printed cerebral cortical tissue into an ex vivo lesioned brain slice
Author
Jin, Yongcheng 1 ; Mikhailova, Ellina 1 ; Lei, Ming 2   VIAFID ORCID Logo  ; Cowley, Sally A. 3   VIAFID ORCID Logo  ; Sun, Tianyi 2 ; Yang, Xingyun 1 ; Zhang, Yujia 1   VIAFID ORCID Logo  ; Liu, Kaili 4 ; Catarino da Silva, Daniel 4 ; Campos Soares, Luana 4 ; Bandiera, Sara 4 ; Szele, Francis G. 4   VIAFID ORCID Logo  ; Molnár, Zoltán 4   VIAFID ORCID Logo  ; Zhou, Linna 5   VIAFID ORCID Logo  ; Bayley, Hagan 1   VIAFID ORCID Logo 

 University of Oxford, Department of Chemistry, Oxford, UK (GRID:grid.4991.5) (ISNI:0000 0004 1936 8948) 
 University of Oxford, Department of Pharmacology, Oxford, UK (GRID:grid.4991.5) (ISNI:0000 0004 1936 8948) 
 University of Oxford, James and Lillian Martin Centre for Stem Cell Research, Sir William Dunn School of Pathology, Oxford, UK (GRID:grid.4991.5) (ISNI:0000 0004 1936 8948) 
 University of Oxford, Department of Physiology, Anatomy and Genetics, Oxford, UK (GRID:grid.4991.5) (ISNI:0000 0004 1936 8948) 
 University of Oxford, Department of Chemistry, Oxford, UK (GRID:grid.4991.5) (ISNI:0000 0004 1936 8948); University of Oxford, Ludwig Institute for Cancer Research, Nuffield Department of Medicine, Oxford, UK (GRID:grid.4991.5) (ISNI:0000 0004 1936 8948) 
Pages
5986
Publication year
2023
Publication date
2023
Publisher
Nature Publishing Group
e-ISSN
20411723
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2872520357
Copyright
© The Author(s) 2023. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.